Preclinical evaluation of enhanced irofulven antitumor activity in an ERCC3 mutant background by in vitro and in vivo tumor models Meeting Abstract


Authors: Topka, S.; Khalil, S.; De Stanchina, E.; Vijai, J.; Offit, K.
Abstract Title: Preclinical evaluation of enhanced irofulven antitumor activity in an ERCC3 mutant background by in vitro and in vivo tumor models
Meeting Title: 109th Annual Meeting of the American Association for Cancer Research (AACR)
Journal Title: Cancer Research
Volume: 78
Issue: 13 Suppl.
Meeting Dates: 2018 Apr 14-18
Meeting Location: Chicago, IL
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2018-07-01
Language: English
ACCESSION: WOS:000468819501080
DOI: 10.1158/1538-7445.Am2018-3258
PROVIDER: wos
Notes: Meeting Abstract: 3258 -- Vijai Joseph's first and last names are reversed on the publisher's record -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Kenneth Offit
    790 Offit
  2. Vijai Joseph
    211 Joseph
  3. Sabine   Topka
    13 Topka
  4. Sara Khalil
    1 Khalil